Madison Gartman Outcome Measures Project Final Outcome Measures Project: Comparison Study of Chemotherapy Outpatients Receiving Nutritional Care and Education Provided by a RD Madison Gartman Dietetic Intern G.V. (Sonny) Montgomery VA Medical Center Madison Gartman Outcome Measures Project Introduction: Nutrition status of patients undergoing chemotherapy is a concern in a variety of healthcare facilities. Chemotherapy involves taking strong drugs, orally or by injection, which kill cancer cells; however, healthy cells, such as bone marrow, lining of the digestive tract, and hair, may be killed during the treatment (American Cancer Society, 2006). During cancer treatment, nutrition plays a vital role in maintaining adequate protein stores and weight management. High protein intake is needed during chemotherapy due to increased energy needs needed during the high intensity treatment. Recent studies have shown serum albumin to drop during the course of chemotherapy, which indicates protein depletion (Inversen et al, 2008; Inversen et al, 2010). Improving patient intake of protein would improve albumin status and nutritional status. Consumption of high protein foods is recommended during chemotherapy while experiencing common side effects, such as low white blood count, nausea, vomiting, poor appetite, constipation, diarrhea, mouth sores, fatigue, and weight loss (American Cancer Society, 2006). Several patients undergoing chemotherapy experience weight loss. Researchers (Inversen et al, 2008; Inversen et al, 2010) have noted muscle mass decreased in patients during cancer treatment, indicating body composition was affected by treatment. Body mass index (BMI) did not decrease as expected (Inversen et al, 2008); however, patients had a median baseline BMI of 25 kg/m2, which is considered overweight by height. A decrease in weight management may be associated with poor appetite, nausea, vomiting, and swallowing difficulty, which are all common side effects of chemotherapy. Patients undergoing chemotherapy would benefit from receiving a nutritional assessment by a Registered Dietitian (RD). An RD provides individualized nutritional care and education for each patient. The Clinical staff within the Department of Nutrition and Food Services at G.V. Madison Gartman Outcome Measures Project (Sonny) Montgomery VA Medical Center will conduct a comparison study on nutritional status of chemotherapy patients since current protocol does not require nutritional screenings or assessments on chemotherapy patients, unless consulted by a Medical Doctor (MD). The purpose of this study is to determine the need for a full-time RD in the chemotherapy department to screen and assess all patients needing nutritional assessments, which will result in improved serum albumin levels and weight management. Madison Gartman Outcome Measures Project Objectives: To determine if nutritional care and education by RDs are an effective form of care in patients undergoing chemotherapy. To determine if medical nutrition therapy initiated by RDs improve serum albumin levels and weight management for patients undergoing chemotherapy. Study Sample: A total of 100 chemotherapy patients will be screened and assessed; 50 patients will be in the intervention group receiving nutritional care and education by an RD, and 50 patients will be in the control group receiving nutritional care and education as needed. Inclusion Criteria: Chemotherapy outpatients at G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS. Chemotherapy outpatients aging 45 years and older, which is due to the current population at G.V. (Sonny) Montgomery VA Medical Center. Exclusion Criteria: Outpatients undergoing dialysis will not be included in the study. Chemotherapy inpatients at G.V. (Sonny) Montgomery VA Medical Center, Jackson, MS, will not be included in the study. Inpatients will not be included because inpatients are followed by RDs while in the hospital. Methodology and Procedures: All data collection will occur at G.V. (Sonny) Montgomery VA Medical Center in Jackson, MS. Madison Gartman Outcome Measures Project The time frame for the data collection is 2 months. The data will be collected by the clinical outpatient RD over the Green Clinic, which is the RD who recieves consults involving chemotherapy outpatients. The unit which will be included in the study is the G.V. (Sonny) Montgomery VA Medical Center chemotherapy clinic. This clinic is also easily accessible for the Green Clinic RD, who will be conducting the data collection. The Green Clinic RD must screen each chemotherapy outpatient for nutritional risks, and assess as needed; however, for the intervention group, the RD must assess and provide individualized nutritional care and education for each patient. Data Collection Methodology (Control Group): A total of 50 chemotherapy outpatients in the control group will be screened using the G.V. (Sonny) Montgomery VA Medical Center nutritional screening tool to determine the nutritional status of patients, as well as perform an assessment as needed. The assessments of the patients within the control group will not be initiated. It is important to obtain nutritional measurements on the control group for comparison purposes. The 50 chemotherapy outpatients will be followed on an as needed basis. The RD will document serum albumin lab data and weights. Data Collection Methodology (Intervention Group): A total of 50 chemotherapy outpatients in the intervention group will be assessed using the G.V. (Sonny) Montgomery VA Medical Center nutritional screening tool to determine the nutritional status of patients, as well as perform assessments on each patient. Madison Gartman Outcome Measures Project Nutritional assessments completed for the 50 outpatients in the intervention group will be done on an individual basis and the American Dietetic Association and American Cancer Society guidelines for nutritional needs of patients undergoing chemotherapy will be used. Nutritional recommendations for the intervention group will be initiated. The Green Clinic RD will follow-up on each patient in the intervention group every every 5-7 days to determine nutritional status, monitor lab values and weight, and make additional nutrition recommendations as needed. Once all of the data has been collected, the intervention and control groups will be compared to determine if an RD is needed full-time in the chemotherapy department to improve the nutritional status of the outpatients and if outpatients improved their serum albumin levels and weight maintenance after having nutritional care and education from an RD. Data Collection Tools: Tools to be used to collect data from outpatients include the G.V. (Sonny) Montgomery VA Medical Center patient computer programs CPRS and Vista. o CPRS is a computer program that entails all patient records. These individual records include appointments, medications, diagnoses, assessments, notes, weights, and lab data. This program will be used to examine and determine the nutritional status and needs of each patient. o Vista is a computer program that entails all patient information, which provides current information pertaining to patients’ diet orders, and allows RDs to perform edit and create nutritional assessments. Vista allows patient information to be Madison Gartman Outcome Measures Project updated and transferred to CPRS to finalize and record nutritional assessments. Data Analysis: All data collected will be organized into a Microsoft Excel Spreadsheet by the Green Clinic RD. Once data is organized, SPSS statistical software will be used to conduct data analysis. The Green Clinic RD will be responsible for utilizing the statistical software. Descriptive statistics will be done on the mean albumin levels and weight changes of patients within the control and intervention groups. This data will be presented in the form of a table for the comparison of each group to determine significant differences. Summary and Production of Reports: Once the study has concluded and the statistical analysis is complete, the Green Clinic RD and the Clinical Nutrition Manager will be responsible for writing the final report within six months from the date the study was complete. The final report will include characteristics of the sample used, results from the data analysis in the form of charts and tables, and a comparison of outcomes between the control and intervention group. Also, the report will discuss the implications from the study that can be incorporated into clinical practice at G.V. (Sonny) Montgomery VA Medical Center, which may entail hiring a full-time RD to oversee the chemotherapy clinic to improve the nutritional status of chemotherapy outpatients. Madison Gartman Outcome Measures Project Appendix: Mean Values Control Intervention Albumin levels Weight changes 5 4.5 Albumin Levels 4 3.5 3 2.5 Nutrition 2 Control 1.5 1 0.5 0 2 4 6 8 # of Persons w/ Weight Changes Weeks of Chemotherapy 5 4.5 4 3.5 3 2.5 2 1.5 1 0.5 0 Nutrition Control 2 4 6 Weeks of Chemotherapy 8 Madison Gartman Outcome Measures Project References: American Cancer Society. (2006). Nutrition for the person with cancer during treatment: a guide for patients and families. www.cancer.org Iversen, P.O., Ukrainchenko, E., Afanasyev, B., Hulbekkmo, K., Choukah, A., Gulbrandsen, N., Wisloff, F., & Tangen, J. (2008). Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia. Leukemia & Lymphoma, 49(10), 1916-1924. doi: 10.1080/10428190802339723 Inversen, P.O., Wisloff, F., & Gulbrandsen, N. (2010). Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support. Clinical Nutrition, 29, 488-491. doi:10.1016/j.clnu.2009.12.002